Form 4: Vivani Medical Director Receives Stock Options
Insider Transaction Report
Vivani Medical, Inc. Director Daniel Bradbury was granted 47,212 non-qualified stock options with an exercise price of $1.23, vesting quarterly through December 31, 2026.
Summary
- Daniel Bradbury, a Director of Vivani Medical, Inc. (VANI), acquired 47,212 non-qualified stock options.
- The transaction date for this award was January 1, 2026.
- Each option has an exercise price of $1.23.
- The options have a 10-year term, expiring on December 31, 2035.
- They vest quarterly through December 31, 2026, contingent on Mr. Bradbury's continued service.
- This award was granted pursuant to the Issuer's non-employee director compensation policy, in lieu of $45,000 in cash retainer fees.
Sentiment
Score: 6
Explanation: The grant of stock options to a director is a standard practice that aligns management and shareholder interests, promoting long-term commitment and performance. It also conserves cash for the company.
Positives
- Aligns the director's interests with those of shareholders through equity ownership, promoting long-term value creation.
- Provides a long-term incentive for the director's continued service and performance.
- Reduces immediate cash outflow for the company by compensating the director with equity instead of cash.
Negatives
- Potential for future dilution of existing shareholders if the options are exercised.
- The director does not receive immediate cash compensation for their service.
Risks
- The value of the options is subject to the future performance and stock price volatility of Vivani Medical, Inc.
- Options may be forfeited if the reporting person's service to the company ceases before the vesting dates.
Future Outlook
The vesting schedule through December 31, 2026, indicates an expectation of Daniel Bradbury's continued service as a director. The 10-year term provides a long-term incentive for value creation.
Industry Context
Compensating non-employee directors with equity, such as stock options, is a common practice across various industries. This approach aims to align the interests of directors with those of shareholders, encouraging long-term value creation and retention.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy Implementation | The award of stock options to Director Daniel Bradbury was made pursuant to Vivani Medical, Inc.'s non-employee director compensation policy, replacing a cash retainer. | 01/01/2026 | This policy change shifts director compensation from cash to equity, aligning director incentives with long-term shareholder value and conserving company cash. |
Stakeholder Impact
- Shareholders: Potential for future dilution if options are exercised, but also benefit from aligned director incentives and cash conservation.
- Director (Daniel Bradbury): Receives long-term equity incentive tied to company performance, rather than immediate cash.
Next Steps
- Daniel Bradbury's continued service as a director through December 31, 2026, is required for the full vesting of the options.
- The options can be exercised at any time after vesting and before their expiration on December 31, 2035.
Key Dates
| Date | Description |
|---|---|
| 01/01/2026 | Date of earliest transaction (option grant date). |
| 12/31/2026 | Final vesting date for the stock options. |
| 12/31/2035 | Expiration date of the stock options. |
Keywords
Vivani Medical, VANI, Stock Options, Director Compensation, Insider Transaction, Form 4, Equity Award, Non-Qualified Stock Option
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.